HDAC3 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

HDAC3 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
HDAC3 shRNA Plasmid (h)

Product Specs
ItemHDAC3 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-35538-SH
Quantity20 µg
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namehistone deacetylase 3
NCBI Gene AliasesHD3, KDAC3, RPD3, RPD3-2
RNA TypeshRNA Clones

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine StarvationAdvanced science (Weinheim, Baden-Wurttemberg, Germany)July 1, 2022Zhang HL, Chen P, Yan HX, Fu GB, Luo FF, Zhang J, Zhao SM, Zhai B, Yu JH, Chen L, et al.

(2) Pharmacological inhibition of HDAC1/3-interacting proteins induced morphological changes, and hindered the cell proliferation and migration of hepatocellular carcinoma cellsEnvironmental science and pollution research internationalSeptember 1, 2021Al-Yhya N, Khan MF, Almeer RS, Alshehri MM, Aldughaim MS, Wadaan MA.

(3) Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2Cell communication and signaling : CCSMarch 18, 2021Huang S, Chen G, Sun J, Chen Y, Wang N, Dong Y, Shen E, Hu Z, Gong W, Jin L, et al.

(4) Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathwayJournal of experimental & clinical cancer research : CRDecember 9, 2020Wang H, Liu YC, Zhu CY, Yan F, Wang MZ, Chen XS, Wang XK, Pang BX, Li YH, Liu DH, et al.

(5) Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapyNature cell biologySeptember 1, 2020Gao Y, Nihira NT, Bu X, Chu C, Zhang J, Kolodziejczyk A, Fan Y, Chan NT, Ma L, Liu J, et al.

(6) HDAC3 inhibition prevents oxygen glucose deprivation/reoxygenation-induced transendothelial permeability by elevating PPARγ activity in vitroJournal of neurochemistryApril 1, 2019Zhao Q, Yu Z, Zhang F, Huang L, Xing C, Liu N, Xu Y, Wang X.

(7) Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosisCell communication and signaling : CCSMarch 12, 2019Zhang M, Pan Y, Tang D, Dorfman RG, Xu L, Zhou Q, Zhou L, Wang Y, Li Y, Yin Y, et al.

(8) Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cellsCancer cell internationalJanuary 1, 2019Huang J, Chang S, Lu Y, Wang J, Si Y, Zhang L, Cheng S, Jiang WG.

(9) HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogueCell death & diseaseMay 24, 2018Gong P, Li K, Li Y, Liu D, Zhao L, Jing Y.

(10) EGF-Mediated Overexpression of Myc Attenuates miR-26b by Recruiting HDAC3 to Induce Epithelial-Mesenchymal Transition of Lens Epithelial CellsBioMed research internationalJanuary 1, 2018Dong N, Xu B, Xu J.

(11) Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cellsOncotargetSeptember 19, 2017Gatla HR, Zou Y, Uddin MM, Vancurova I.

(12) Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cellsExperimental biology and medicine (Maywood, N.J.)March 1, 2017Bai Y, Du S, Li F, Huang F, Deng R, Zhou J, Chen D.

(13) Transcriptional repression of HER2 by ANO1 Cl(-) channel inhibition in human breast cancer cells with resistance to trastuzumabBiochemical and biophysical research communicationsJanuary 1, 2017Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K, Ohya S.

(14) Down-Regulation of Ca(2+)-Activated K⁺ Channel K(Ca)1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor AgonistsInternational journal of molecular sciencesDecember 11, 2016Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S.

(15) Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cellsJournal of cellular and molecular medicineDecember 1, 2016Choi SY, Kee HJ, Kurz T, Hansen FK, Ryu Y, Kim GR, Lin MQ, Jin L, Piao ZH, Jeong MH.

(16) Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cellsPharmacology research & perspectivesApril 1, 2016Ohya S, Kanatsuka S, Hatano N, Kito H, Matsui A, Fujimoto M, Matsuba S, Niwa S, Zhan P, Suzuki T, et al.

(17) HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of MacrophagesThe Journal of biological chemistryFebruary 5, 2016Romani B, Baygloo NS, Hamidi-Fard M, Aghasadeghi MR, Allahbakhshi E.

(18) Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIPTranslational oncologyFebruary 1, 2016Liu J, Li G, Wang X, Wang L, Zhao R, Wang J, Kong Y, Ding J, Li J, Zhang L.

(19) Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 functionAmerican journal of physiology. Lung cellular and molecular physiologyDecember 15, 2015Joshi AD, Barabutis N, Birmpas C, Dimitropoulou C, Thangjam G, Cherian-Shaw M, Dennison J, Catravas JD.

(20) Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradationOncotargetSeptember 22, 2015Seo SK, Hwang CS, Choe TB, Hong SI, Yi JY, Hwang SG, Lee HG, Oh ST, Lee YH, Park IC.

Be the First to Write a Review!